Readership
Academics, Advanced Practice Nurses, Allied Health Professionals, Biomedical Researchers, Cardiologists, Clinical Pharmacologists, Clinicians, Dermatologists, Endocrinologists, Epidemiologists, Gastroenterologists, General Practitioners, Health Scientists, Hepatologists, Immunologists, Industrial Scientists, Infectious Disease Specialists, Nephrologists, Neurologists, Pathologists, Pharmaco-Epidemiologists, Pharmacologists, Physicians, Physicians - Medicine, Researchers, Scientists, Vascular Medicine Specialists
Scope
Therapeutic Advances in Rare Disease delivers the highest quality peer-reviewed articles, reviews, and scholarly comment on the diagnosis and medical treatment of rare diseases and orphan drugs. The journal has a strong research and clinical focus and is aimed at clinicians, researchers in both academia and healthcare industries, as well as manufacturers through to policy-makers, providing an online forum for publishing the highest quality articles in this area.
The editors welcome original research articles across all areas of rare disease including: Clinical genetics and genomics · Dysmorphology
· Ethical and legal perspectives · Inherited metabolic diseases · Lysosomal storage diseases · Mitochondrial Diseases · Orphan Drugs · Rare bone diseases and skeletal dysplasias · Rare cardiovascular diseases · Rare coagulation diseases · Rare endocrinological diseases · Rare gastrointestinal diseases · Rare immune deficiencies · Rare infectious diseases · Rare kidney diseases · Rare neurological diseases · Rare ophthalmological diseases · Rare respiratory diseases · Rare skin diseases · Rare tumors · Regulatory, reimbursement and government policy